Literature DB >> 1935979

Limited proteolysis of tetanus toxin. Relation to activity and identification of cleavage sites.

K G Krieglstein1, A H Henschen, U Weller, E Habermann.   

Abstract

Tetanus toxin is synthesized by Clostridium tetani as a 151-kDa peptide chain. The primary gene product is processed post-translationally by removal of the initiating methionine residue, formation of disulfide bridges and limited proteolysis by bacterial or exogenous proteinases. The mature toxins consist of a 52-kDa light chain and a 98-kDa heavy chain, linked together by a disulfide bond. Proteolytic nicking is accompanied by increased pharmacological potency. To identify the structural alterations involved, single-chain toxin has been subjected to limited proteolysis with various enzymes. The new N-termini have been determined by Edman degradation and the C-termini by isolation of short C-terminal peptide fragments and subsequent analysis of the sequence and composition. All two-chain toxins result from proteolytic nicking within the 17-residue segment of residues 445-461. Thus, the protease(s) of the culture broth cleave on the C-terminal side of Glu449 and partially Ala456, giving rise to two heavy chain N-termini. Trypsin and clostripain first attack the C-terminal of Arg454 and later Arg448, whereas endoproteinase Arg-C cleaves the former bond only. Chymotrypsin and endoproteinase Glu-C each split a single peptide bond, i.e. that located after Tyr452 and Glu449, respectively. Papain gives rise to a large number of cleavages within the 17-residue segment, the new C-terminus being Thr445 or Asn446 and the new N-terminus being Asp460 or Leu461. Further papain digestion leads to an additional cleavage within the heavy chain between Ser863 and Lys864. The original N-terminal Pro1 and C-terminal Asp1314, predicted from the nucleotide sequence, are conserved in all proteolytic digests. The pharmacological activity of the various two-chain toxins was 5-11 times that of the single-chain toxin, as estimated from the inhibition of [3H]noradrenaline release from rat-brain homogenate. The present data on the processing and activation by limited proteolysis prove the existence of several active tetanus isotoxins. These data, together with our previous data on the localization of disulfide bridges and sulfhydryl groups (Krieglstein, K., Henschen, A., Weller, U. & Habermann, E. (1990) Eur. J. Biochem. 188, 39-45), provide the detailed protein chemical characterization of the tetanus isotoxins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1935979     DOI: 10.1111/j.1432-1033.1991.tb16342.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  The structure of the tetanus toxin reveals pH-mediated domain dynamics.

Authors:  Geoffrey Masuyer; Julian Conrad; Pål Stenmark
Journal:  EMBO Rep       Date:  2017-06-23       Impact factor: 8.807

2.  Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.

Authors:  Miri Blank; Ilan Krause; Mati Fridkin; Nathan Keller; Juri Kopolovic; Iris Goldberg; Ana Tobar; Yehuda Shoenfeld
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 3.  Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases.

Authors:  V M Gordon; S H Leppla
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

4.  Modulation of the intracellular stability and toxicity of diphtheria toxin through degradation by the N-end rule pathway.

Authors:  P O Falnes; S Olsnes
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

5.  Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells.

Authors:  E Erdal; F Bartels; T Binscheck; G Erdmann; J Frevert; A Kistner; U Weller; J Wever; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

6.  Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells.

Authors:  Faith C Blum; Amanda Przedpelski; William H Tepp; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

Review 7.  Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

Authors:  R Pellizzari; O Rossetto; G Schiavo; C Montecucco
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

8.  The apoptogenic toxin AIP56 is a metalloprotease A-B toxin that cleaves NF-κb P65.

Authors:  Daniela S Silva; Liliana M G Pereira; Ana R Moreira; Frederico Ferreira-da-Silva; Rui M Brito; Tiago Q Faria; Irene Zornetta; Cesare Montecucco; Pedro Oliveira; Jorge E Azevedo; Pedro J B Pereira; Sandra Macedo-Ribeiro; Ana do Vale; Nuno M S dos Santos
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

Review 9.  The role of the single interchains disulfide bond in tetanus and botulinum neurotoxins and the development of antitetanus and antibotulism drugs.

Authors:  Ornella Rossetto; Marco Pirazzini; Florigio Lista; Cesare Montecucco
Journal:  Cell Microbiol       Date:  2019-05-23       Impact factor: 3.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.